设为首页 电子邮箱 联系我们

本刊最新招聘信息请见“通知公告”!  本刊投稿系统试运行中,欢迎投稿!如投稿有问题,可直接将稿件发送至zgyy8888@163.com

 

主管单位:中华人民共和国   

国家卫生健康委员会

主办单位:中国医师协会
总编辑:
杨秋

编辑部主任:吴翔宇

邮发代号:80-528
定价:28.00元
全年:336.00元
Email:zgyy8888@163.com
电话(传真):010-64428528;
010-64456116(总编室)

                  

过刊目录

2019 年第 2 期 第 14 卷

美托洛尔联合曲美他嗪对老年高血压合并慢性心力衰竭患者的疗效

Effect of metoprolol combined with trimetazidine on senile patients with hypertension and chronic heart failure

作者:梁国君廖桂华

英文作者:

单位:610000成都军区总医院干部病房一病区(梁国君),干部病房四病区(廖桂华)

英文单位:

关键词:高血压;慢性心力衰竭;美托洛尔;曲美他嗪;Th17细胞

英文关键词:

  • 摘要:
  • 【摘要】目的    探讨美托洛尔联合曲美他嗪对老年高血压合并慢性心力衰竭患者的疗效。方法    选取2016年1月至2017年12月成都军区总医院收治的86例老年高血压合并慢性心力衰竭患者为研究对象,按照随机数字表法分为对照组和观察组,各43例。对照组在常规治疗基础上给予琥珀酸美托洛尔缓释片治疗;观察组在对照组基础上给予曲美他嗪片治疗。2组均治疗6个月。比较2组临床疗效,治疗前后心率、血压、心功能指标、CD+4CD+25调节性T细胞和辅助性T细胞17(Th17)细胞表达水平,以及用药期间不良反应发生情况。结果    治疗后,观察组总有效率明显高于对照组[90.7%(39/43)比69.8%(30/43)],差异有统计学意义(P<0.01)。治疗后,2组患者心率、血压明显低于治疗前,且观察组心率明显低于对照组[(85±8)次/min比(97±8)次/min],差异有统计学意义(P<0.05)。治疗后,观察组患者左心室射血分数、左心室收缩末期内径、左心室舒张末期内径改善均较对照组明显[(50.2±3.3)%比(45.2±2.9)%、(34.3±2.1)mm比(38.7±2.5)mm、(54±3)mm比(58±4)mm],差异均有统计学意义(均P<0.05)。治疗后,2组CD+4CD+25调节性T细胞细胞比例明显升高,且观察组明显高于对照组,Th17细胞比例明显下降,且观察组明显低于对照组,差异均有统计学意义(均P<0.05)。治疗期间,2组不良反应发生率比较,差异无统计学意义(P>0.05)。结论    美托洛尔联合曲美他嗪治疗老年高血压合并慢性心力衰竭,能明显改善心率,稳定各项心功能指标,调节外周血Th17细胞等炎症因子,缓解免疫系统紊乱,且安全性较好。

  • 【Abstract】Objective    To evaluate the effect of metoprolol combined with trimetazidine on senile patients with hypertension and chronic heart failure. Methods    Totally 86 senile patients with hypertension and chronic heart failure admitted to Chengdu Military General Hospital from January 2016 to December 2017 were randomly divided into control group and observation group, with 43 cases in each group. The control group took metoprolol succinate sustained-release tablets and the observation group took trimetazidine tablets additionally; both groups were treated for 6 months. Heart rate, blood pressure, cardiac function, CD+4CD+25 regulatory T cell(Treg), helper T cell 17(Th17) and adverse drug reactions were analyzed. Results    Total effective rate in observation group was significantly higher than that in control group[90.7%(39/43) vs 69.8%(30/43)](P<0.01). After treatment, heart rate and blood pressure were significantly lower than those before treatment in both groups; heart rate in observation group was significantly lower than that in control group[(85±8)times/min vs (97±8)times/min](P<0.05). After treatment, left ventricular ejection fraction, left ventricular end-systolic diameter and left ventricular end-diastolic diameter in observation group were significantly improved compared to those in control group[(50.2±3.3)% vs (45.2±2.9)%, (34.3±2.1)mm vs (38.7±2.5)mm, (54±3)mm vs (58±4)mm](P<0.05). After treatment, CD+4CD+25 Treg ratio significantly increased and Th17 ratio significantly decreased in both groups; CD+4CD+25 Treg ratio in observation group was significantly higher and Th17 ratio was lower than those in control group(P<0.05). There was no significant difference of the incidence of adverse reactions between groups(P>0.05). Conclusion    Metoprolol combined with trimetazidine treating senile hypertension with chronic heart failure can significantly improve heart rate and cardiac function, modulate peripheral blood Th17 and relieve immune disorders with good safety.

copyright 《中国医药》杂志编辑部
地址:北京市朝阳区安贞路2号首都医科大学附属北京安贞医院北楼二层
电话:010-64456116 传真:010-64428528 邮编:100029 Email: zgyy8888@163.com
网址:www.chinamedicinej.com 京ICP备2020043099号-3

当您在使用本网站投稿遇到困难时,请直接将稿件投送到编辑部邮箱zgyy8888@163.com。







安卓


苹果

关闭